Scandonest 3% Plain | Mepivacaine Hydrochloride Injection while Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Scandonest 3% Plain | Mepivacaine Hydrochloride Injection is safe in breast-feeding or not.

What is Scandonest 3% Plain | Mepivacaine Hydrochloride Injection used for?


: Mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients.

Is Scandonest 3% Plain | Mepivacaine Hydrochloride Injection safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Scandonest 3% Plain | Mepivacaine Hydrochloride Injection low risk for breastfeeding
Mepivacaine hydrochloride is the one and only active ingredient present in Scandonest 3% Plain | Mepivacaine Hydrochloride Injection. Mepivacaine hydrochloride in itself is a low risk drug for lactation so it is easy to understand that Scandonest 3% Plain | Mepivacaine Hydrochloride Injection also comes in category of Low Risk item while breastfeeding. Below is the summary of Mepivacaine hydrochloride in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this solution is administered to a nursing woman.

Scandonest 3% Plain | Mepivacaine Hydrochloride Injection Breastfeeding Analsys


Mepivacaine hydrochloride while Breastfeeding

Low Risk

CAS Number: 96-88-8

Scandonest 3% Plain | Mepivacaine Hydrochloride Injection and breastfeeding

Local anesthetic agent which is used for infiltration and nerve-blocking procedures included Epidural anesthesia. At latest update, published data concerning excretion into breast milk were not found. However, because its chemical structure is closely related to Bupivacaine, it is expected to occur in a non-significant level. There is controversy about the effect of drug-mediated analgesia used during the child birth (e.g. epidural injection of local anesthetics plus Fentanyl or alone) on the mature milk coming in, whether by delaying the onset of Lactogenesis phase II, or, by affecting the ability of the child for sucking. Some studies have shown a higher risk for delay of initiation of Lactogenesis phase II (milk coming in) longer than 3 post-natal days, but without effect on loss of initial weight. On other studies, the newborn infant appears to have higher risk for delay on first latch-on, higher body temperature and irritability or somnolence. Because of the latter, it is argued that those mothers would be in need of more support on breastfeeding when they have received ante or intra partum analgesia. However, other authors have failed to find the same results. There consensus on the achievement of higher milk production and higher body weight increase in the neonate with an adequate pharmacological control of pain after C-section or vaginal childbirth. Considering the fact that Mepivacaine readily crosses the placenta barrier, with a elimination-time period that is slower than adults (T ½ = 9 hours), it is safer the choice of Bupivacaine in case of prematurity or during the immediate neonatal period.


Scandonest 3% Plain | Mepivacaine Hydrochloride Injection Breastfeeding Analsys - 2


Mepivacaine hydrochloride while Breastfeeding

CAS Number: 96-88-8

No information is available on the use of mepivacaine during breastfeeding. Based on the low excretion of other local anesthetics into breastmilk, a single dose of mepivacaine during breastfeeding is unlikely to adversely affect the breastfed infant. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Mepivacaine given during labor as a local anesthetic to the mother has been reported to interfere with initial nursing behavior of some infants, but not weight gain during the first 5 days postpartum. Labor pain medication may delay the onset of lactation. More study is required to clarify the effect of mepivacaine during labor on breastfeeding outcome.


Is Scandonest 3% Plain | Mepivacaine Hydrochloride Injection safe while breastfeeding

I am nursing mother and I have already used Scandonest 3% Plain | Mepivacaine Hydrochloride Injection, what should I do?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Scandonest 3% Plain | Mepivacaine Hydrochloride Injection then you shall inform your doctor, But you should not be worried too much as Scandonest 3% Plain | Mepivacaine Hydrochloride Injection comes in category of low risk drug.


My health care provider has asked me to use Scandonest 3% Plain | Mepivacaine Hydrochloride Injection, what to do?

Though Scandonest 3% Plain | Mepivacaine Hydrochloride Injection dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Scandonest 3% Plain | Mepivacaine Hydrochloride Injection, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Scandonest 3% Plain | Mepivacaine Hydrochloride Injection in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week